PATENT CLAIM ANALYSIS

Application Number: 15755792
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "013300"]

Abstract:
The present invention relates to novel cyclic peptidomimetics, pharmaceutical compositions containing them and their use in the treatment of diseases associated with angiogenesis especially tumors and chronic inflammation in psoriasis, diabetes, degenerative diseases of the eye (ARMD), nephropathy and neuropathy.

Claim (Index 4):
Cyclic peptidomimetics according to any form the claims from  1  to  3 , characterized in that they are monomers with a general formula: where m=from 0 to 4, n=from 0 to 4, i=3 or 4, and where A is selected from the group: \u2014CO\u2014NH\u2014; \u2014NH\u2014CO\u2014; \u2014S\u2014S\u2014; \u2014HN\u2014CO\u2014NH\u2014, CH 2 \u2014CH 2 \u2014; \u2014CH 2 \u2014NH\u2014; \u2014NH\u2014CH 2 \u2014,\n B is selected from the group: \n \u2014(CH 2 ) d \u2014NH 2 , where d=from 0 to 4; \u2003where k=3 or 4, wherein at each chiral center may be L or D configuration or the R or S, and pharmaceutically acceptable salts, hydrates or other pharmaceutically acceptable complexes.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.23684
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14913380', '13886864', '13311817', '14379484', '14024961']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7644763233198977
- 35 USC 102 Novelty (BERT): 0.545021444884768
- Combined Prediction Score: 0.7425308354763848
- Mean Citation Score: 302.682876
- Max Citation Score: 377.87958
- Similarity Product: 270.7199236659193

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test